We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy and safety of ACEI plus tanshinone for acute exacerbation of pulmonary heart disease: a meta-analysis.
- Authors
Min Li; Lulu Chang; Xiangfeng Yue; Shuzhang Du
- Abstract
Acute exacerbation of pulmonary heart disease (AECPHD) is life-threatening. Conventional therapy plus angiotensinconverting enzyme inhibitors (ACEI) is not always practical. Recent trials have suggested the beneficial effects of the combination of ACEI and tanshinone on AECPHD. In the present study, we aimed to evaluate its efficacy and safety by meta-analysis systematically. The result indicated that combination of ACEI and tanshinone was more effective than ACEI monotherapy in AECPHD, as represented by treatment efficiency and mean pulmonary arterial pressure, PaCO2, and PaO2. However, the incidence of adverse events of combined therapy was higher than the control group, while the result of the analysis for adverse events was unstable. Further large-scale, multicenter, and rigorously designed randomized controlled trials (RCT) are needed to evaluate the efficacy and safety of combined therapy.
- Subjects
DISEASE exacerbation; LUNG diseases; HEART diseases; RANDOMIZED controlled trials; ENZYME inhibitors; SAFETY
- Publication
Journal of Chinese Pharmaceutical Sciences, 2022, Vol 31, Issue 11, p853
- ISSN
1003-1057
- Publication type
Article
- DOI
10.5246/jcps.2022.11.072